Sanofi-Aventis Healthcare Pty Ltd v Russian Federation

Sanofi-Aventis Healthcare Pty Ltd (the opponent) opposed the registration of a trade mark by the Russian Federation (the applicant) in Australia. The dispute concerned whether the applicant's proposed trade mark was deceptively similar to existing registered trade marks owned by Sanofi-Aventis Healthcare Pty Ltd. The decision was made by Debrett Lyons, a Hearing Officer at the Trade Marks Hearings.

The primary legal issue before the Hearing Officer was whether the opposed trade mark was deceptively similar to the opponent's registered trade marks, as contemplated by section 44 of the relevant Act. This assessment would determine whether the opponent had established a valid ground for opposition.

The Hearing Officer found that the opposed trade mark was indeed deceptively similar to the opponent's registered trade marks. Applying the principles of deceptive similarity, the Hearing Officer concluded that the opponent had successfully established its ground for opposition under section 44 of the Act. Consequently, the Hearing Officer refused to extend protection of the opposed trade mark to Australia for all the goods listed in the International Registration Designating Australia (IRDA). The opponent was also awarded its costs on the official scale, having been successful in the proceedings.